Kidney Stone Management Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	135 Pages	Fortune Business Insights Pvt. Ltd.	December, 2024	FOB19410845

Best Price Guarantee
Price	from $4,850
Length	135 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	December, 2024
SKU	FOB19410845

Kidney Stone Management Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Kidney Stone Management Market

The kidney stone management market size was valued at USD 1.47 million in 2019, and the market is now projected to grow from USD 1.47 million in 2019 to USD 2.21 million by 2027, exhibiting a CAGR of 5.3% during the forecast period of 2019-2027.

Pandemic negatively impacted the kidney stone management market growth, leading to a drop in income and a slow analysis cost. Small hospitals and nursing houses were pressured to quick close all the way right down to save you contamination transmission and divert healthcare sources. Factors hampering the market consist of poor supply chain management, confined raw material availability, sluggish medical tool manufacturing, and monetary slowdown.

Kidney stone diseases are growing globally, with urolithiasis affecting 12% of the worldwide populace. In countries with immoderate standards of life, which include the U.S., Canada, and Sweden, the superiority of this sickness is over 10%. Other diseases like weight problems, diabetes, and excessive blood strain may additionally boom the danger of kidney stones. There are confined alternatives for powerful drug remedies.

New strategies and devices in stone ailment remedies are revolutionizing healthcare providers and patients. These encompass miniaturized surgical procedure, holmium laser technologies, and disposable ureteroscopes. Lumenis introduced clinical evidence in lithotripsy and benign prostatic hyperplasia treatments using MOSES Technology, which makes use of a notably energized laser to break kidney stones without injuring surrounding tissues and minimum bleeding.

Comprehensive Analysis of Kidney Stone Management Market

The marketplace is segmented into lithotripsy, ureteroscopy, and percutaneous Nephrolithonomy (PCNL). The ureteroscopy segment dominated because of its minimally invasiveness and occasional recurrence charge. This segment is expected to record a high CAGR. Hospitals, specialty clinics, and ambulatory surgical centres are the end-user segments. Hospitals dominate the market due to the growing number of patients with kidney stones and adoption of advanced technologies. However, specialty clinics are projected to experience the highest growth due to the increasing number of skilled surgeons and favourable reimbursement policies offered by these clinics.

The North America region lead the kidney stone management market share by benefitting a market size of USD 555.7 million in 2019 due to using multiplied incidence and prevalence of stone diseases, favorable compensation regulations, and growing patient consciousness about new remedy alternatives. Europe holds the second one largest share because of rising kidney stone incidences, better popularity of technologically advanced merchandise, rising healthcare fees, and favorable compensation rules. These factors make a contribution to the market's growth.

The urolithiasis control devices market is ruled by leading players like Boston Scientific Corporation, Olympus Corporation, Karl STORZ SE and Co. KG, and Richard Wolf GmbH. Their assorted and technologically advanced product portfolio and worldwide enlargement make a contribution to their dominance. They additionally emphasize partnerships and acquisition techniques to attract excessive marketplace sales. Key organizations encompass Boston Scientific Corporation, Olympus Corp., STORZ MEDICAL AG, Lumenis, EDAP TMS and DirexGroup.

Boston Scientific Corporation brought the LithoVue Empower Retrieval Device in September 2018 for the retrieval of kidney stones through bendy ureteroscopy (URS) within the US and Europe.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2016-2027

Base Year 2019

Forecast Period 2020-2027

Historical Period 2016-2018

Unit Value (USD billion)

SegmentationBy Type

Lithotripsy

Ureteroscopy

Percutaneous Nephrolithonomy (PCNL)

By End User

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Geography

• North America (the U.S., and Canada)

• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)

• Latin America (Brazil, Mexico, and the Rest of Latin America)

• Middle East and Africa (South Africa, GCC, and the Rest of Middle East

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities
4. Key Insights: 4.1. Reimbursement Scenario by Key Countries/Region; 4.2. Recent Advancements in Kidney Stone Management Devices; 4.3. Key Industry Trends; 4.4. Key Industry Developments (Mergers, Acquisitions, and Partnerships); 4.5. Impact of COVID-19 on Kidney Stone Management Devices Market
5. Global Kidney Stone Management Market Analysis, Insights and Forecast, 2016-2027: 5.1. Key Findings / Summary; 5.2. Market Analysis, Insights and Forecast – By Type; 5.2.1. Lithotripsy; 5.2.2. Ureteroscopy; 5.2.3. Percutaneous Nephrolithonomy (PCNL); 5.3. Market Analysis, Insights and Forecast – By End User; 5.3.1. Hospitals; 5.3.2. Specialty Clinics; 5.3.3. Ambulatory Surgical Centers; 5.4. Market Analysis, Insights and Forecast – By Region; 5.4.1. North America; 5.4.2. Europe; 5.4.3. Asia Pacific; 5.4.4. Latin America; 5.4.5. Middle East & Africa
6. North America Kidney Stone Management Market Analysis, Insights and Forecast, 2016-2027: 6.1. Key Findings / Summary; 6.2. Market Analysis – By Type; 6.2.1. Lithotripsy; 6.2.2. Ureteroscopy; 6.2.3. Percutaneous Nephrolithonomy (PCNL); 6.3. Market Analysis – By End User; 6.3.1. Hospitals; 6.3.2. Specialty Clinics; 6.3.3. Ambulatory Surgical Centers; 6.4. Market Analysis – By Country; 6.4.1. U.S.; 6.4.2. Canada
7. Europe Kidney Stone Management Market Analysis, Insights and Forecast, 2016-2027: 7.1. Key Findings / Summary; 7.2. Market Analysis – By Type; 7.2.1. Lithotripsy; 7.2.2. Ureteroscopy; 7.2.3. Percutaneous Nephrolithonomy (PCNL); 7.3. Market Analysis – By End User; 7.3.1. Hospitals; 7.3.2. Specialty Clinics; 7.3.3. Ambulatory Surgical Centers; 7.4. Market Analysis – By Country/Sub-region; 7.4.1. U.K.; 7.4.2. Germany; 7.4.3. France; 7.4.4. Spain; 7.4.5. Italy; 7.4.6. Scandinavia; 7.4.7. Rest of Europe
8. Asia Pacific Kidney Stone Management Market Analysis, Insights and Forecast, 2016-2027: 8.1. Key Findings / Summary; 8.2. Market Analysis – By Type; 8.2.1. Lithotripsy; 8.2.2. Ureteroscopy; 8.2.3. Percutaneous Nephrolithonomy (PCNL); 8.3. Market Analysis – By End User; 8.3.1. Hospitals; 8.3.2. Specialty Clinics; 8.3.3. Ambulatory Surgical Centers; 8.4. Market Analysis – By Country/Sub-region; 8.4.1. Japan; 8.4.2. China; 8.4.3. India; 8.4.4. Australia; 8.4.5. Southeast Asia; 8.4.6. Rest of Asia Pacific
9. Latin America Kidney Stone Management Market Analysis, Insights and Forecast, 2016-2027: 9.1. Key Findings / Summary; 9.2. Market Analysis – By Type; 9.2.1. Lithotripsy; 9.2.2. Ureteroscopy; 9.2.3. Percutaneous Nephrolithonomy (PCNL); 9.3. Market Analysis – By End User; 9.3.1. Hospitals; 9.3.2. Specialty Clinics; 9.3.3. Ambulatory Surgical Centers; 9.4. Market Analysis – By Country/Sub-region; 9.4.1. Brazil; 9.4.2. Mexico; 9.4.3. Rest of Latin America
10. Middle East & Africa Kidney Stone Management Market Analysis, Insights and Forecast, 2016-2027: 10.1. Key Findings / Summary; 10.2. Market Analysis – By Type; 10.2.1. Lithotripsy; 10.2.2. Ureteroscopy; 10.2.3. Percutaneous Nephrolithonomy (PCNL); 10.3. Market Analysis – By End User; 10.3.1. Hospitals; 10.3.2. Specialty Clinics; 10.3.3. Ambulatory Surgical Centers; 10.4. Market Analysis – By Country/Sub-region; 10.4.1. GCC Countries; 10.4.2. South Africa; 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Key Industry Developments; 11.2. Global Market Share Analysis (2019); 11.3. Competition Dashboard; 11.4. Comparative Analysis – Major Players; 11.5. Company Profiles (Overview, Products & Services, SWOT analysis, Recent developments, Strategies, Financials (based on availability)); 11.5.1. Cook Medical Inc.; 11.5.1.1. Overview,; 11.5.1.2. Products & Services,; 11.5.1.3. SWOT analysis,; 11.5.1.4. Recent developments,; 11.5.1.5. Strategies,; 11.5.1.6. Financials (based on availability); 11.5.2. Olympus Corp.; 11.5.2.1. Overview,; 11.5.2.2. Products & Services,; 11.5.2.3. SWOT analysis,; 11.5.2.4. Recent developments,; 11.5.2.5. Strategies,; 11.5.2.6. Financials (based on availability); 11.5.3. C.R. Bard Inc.; 11.5.3.1. Overview,; 11.5.3.2. Products & Services,; 11.5.3.3. SWOT analysis,; 11.5.3.4. Recent developments,; 11.5.3.5. Strategies,; 11.5.3.6. Financials (based on availability); 11.5.4. Boston Scientific Corporation; 11.5.4.1. Overview,; 11.5.4.2. Products & Services,; 11.5.4.3. SWOT analysis,; 11.5.4.4. Recent developments,; 11.5.4.5. Strategies,; 11.5.4.6. Financials (based on availability); 11.5.5. STORZ MEDICAL AG; 11.5.5.1. Overview,; 11.5.5.2. Products & Services,; 11.5.5.3. SWOT analysis,; 11.5.5.4. Recent developments,; 11.5.5.5. Strategies,; 11.5.5.6. Financials (based on availability); 11.5.6. Richard Wolf GmbH; 11.5.6.1. Overview,; 11.5.6.2. Products & Services,; 11.5.6.3. SWOT analysis,; 11.5.6.4. Recent developments,; 11.5.6.5. Strategies,; 11.5.6.6. Financials (based on availability); 11.5.7. Lumenis; 11.5.7.1. Overview,; 11.5.7.2. Products & Services,; 11.5.7.3. SWOT analysis,; 11.5.7.4. Recent developments,; 11.5.7.5. Strategies,; 11.5.7.6. Financials (based on availability); 11.5.8. EDAP TMS; 11.5.8.1. Overview,; 11.5.8.2. Products & Services,; 11.5.8.3. SWOT analysis,; 11.5.8.4. Recent developments,; 11.5.8.5. Strategies,; 11.5.8.6. Financials (based on availability); 11.5.9. DirexGroup; 11.5.9.1. Overview,; 11.5.9.2. Products & Services,; 11.5.9.3. SWOT analysis,; 11.5.9.4. Recent developments,; 11.5.9.5. Strategies,; 11.5.9.6. Financials (based on availability); 11.5.10. Other prominent players; 11.5.10.1. Overview,; 11.5.10.2. Products & Services,; 11.5.10.3. SWOT analysis,; 11.5.10.4. Recent developments,; 11.5.10.5. Strategies,; 11.5.10.6. Financials (based on availability)
12. Strategic Recommendations